rs121907913

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong

The ENST00000640872.1(PAX6):​c.-333C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 31)

Consequence

PAX6
ENST00000640872.1 5_prime_UTR_premature_start_codon_gain

Scores

14
4

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 0.999

Publications

19 publications found
Variant links:
Genes affected
PAX6 (HGNC:8620): (paired box 6) This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter's anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]
PAX6 Gene-Disease associations (from GenCC):
  • aniridia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • PAX6-related ocular dysgenesis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Peters anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • coloboma, ocular, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • foveal hypoplasia-presenile cataract syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated aniridia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated optic nerve hypoplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant keratitis
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.99
PP5
Variant 11-31802769-G-A is Pathogenic according to our data. Variant chr11-31802769-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 800389.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000640872.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PAX6
NM_001368894.2
MANE Select
c.76C>Tp.Arg26Trp
missense
Exon 5 of 14NP_001355823.1
PAX6
NM_001368929.2
c.-375C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9NP_001355858.1
PAX6
NM_001310160.2
c.-706C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 10NP_001297089.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PAX6
ENST00000640872.1
TSL:1
c.-333C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 9ENSP00000491065.1
PAX6
ENST00000640368.2
TSL:5 MANE Select
c.76C>Tp.Arg26Trp
missense
Exon 5 of 14ENSP00000492024.1
PAX6
ENST00000419022.6
TSL:1
c.76C>Tp.Arg26Trp
missense
Exon 5 of 14ENSP00000404100.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Aniridia 1 Pathogenic:1
Aug 15, 2019
Wessex Regional Genetics Laboratory, Salisbury District Hospital
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

Irido-corneo-trabecular dysgenesis Pathogenic:1
Jul 28, 2023
Molecular Medicine, University of Pavia
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Pathogenic:1
Sep 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 26 of the PAX6 protein (p.Arg26Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of aniridia (PMID: 27878435, 32360764). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 800389). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PAX6 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg26 amino acid residue in PAX6. Other variant(s) that disrupt this residue have been observed in individuals with PAX6-related conditions (PMID: 18483559, 31700164, 34101622), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.99
D
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.95
D
MutationAssessor
Pathogenic
3.8
H
PhyloP100
1.0
PrimateAI
Pathogenic
0.93
D
PROVEAN
Pathogenic
-6.7
D
REVEL
Pathogenic
0.94
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.92
MutPred
0.95
Loss of disorder (P = 0.0155)
MVP
1.0
MPC
3.3
ClinPred
1.0
D
GERP RS
3.5
PromoterAI
-0.099
Neutral
Varity_R
0.97
gMVP
0.97
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121907913; hg19: chr11-31824317; API